Share
Hemab Therapeutics Holdings, Inc. Common Stock Stocks
$ 26.45Last Updated 17.06.2026
Issuer Rating
Performance
Modest
Risk
Considerable
Recommendation
Sell
Market Cap
$ 51.24M
$ 26.45
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors
Latest news
Risks
- Default riskData is available to registered users only
- VolatilityData is available to registered users only
- Selling difficultyData is available to registered users only
- Stress testData is available to registered users only
- Country risksData is available to registered users only
- Other risksData is available to registered users only
Sign up to access detailed risk analysis
About
No company description
Risks
- Default riskData is available to registered users only
- VolatilityData is available to registered users only
- Selling difficultyData is available to registered users only
- Stress testData is available to registered users only
- Country risksData is available to registered users only
- Other risksData is available to registered users only
Sign up to access detailed risk analysis